Skip to main content
Clinical Trials/NL-OMON46687
NL-OMON46687RecruitingNot Applicable

Prospective Longitudinal Study Using Functional MRI and Met-PET Imaging for Treatment Evaluation in Glioblastoma Patients - MRI and MET-PET treatment evaluation in glioblastoma

niversitair Medisch Centrum Groningen0 sites40 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • - Adult patients with a new primary glioblastoma.
  • - Scheduled to undergo standard treatment consisting of surgical resection followed by
  • concomitant chemoradiation and adjuvant chemotherapy according to the Stupp protocol.
  • - Informed consent must be obtained
  • - No exclusion criteria

Exclusion Criteria

  • - Patients with a recurrent or secondary glioblastoma
  • - Patients with a other intracranial tumour
  • - Patients with infratentorial glioblastoma
  • - Prior brain surgery or irradiation of the head
  • - Patients not scheduled for standard therapy (e.g. who will receive a biopsy without further
  • - Minors (<18 years of age)

Investigators

Similar Trials